申请人:Ontario Institute for Cancer Research (OICR)
公开号:US20200397916A1
公开(公告)日:2020-12-24
The present application is directed to compounds of Formula (I)-(VI): (I), (II), (III), (IV), (V) (VI), (VII) and (VIII), compositions comprising these compounds and their uses, for example as medicaments and/or diagnostics.